ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/07/11 | 1,238 | 1,239 | 1,173 | 1,180 | -48 | -3.9% | 937,600 |
| 2022/07/08 | 1,235 | 1,254 | 1,213 | 1,228 | +5 | +0.4% | 635,300 |
| 2022/07/07 | 1,253 | 1,255 | 1,207 | 1,223 | -19 | -1.5% | 807,000 |
| 2022/07/06 | 1,183 | 1,255 | 1,183 | 1,242 | +77 | +6.6% | 1,401,300 |
| 2022/07/05 | 1,141 | 1,166 | 1,136 | 1,165 | +29 | +2.6% | 621,000 |
| 2022/07/04 | 1,138 | 1,149 | 1,122 | 1,136 | +16 | +1.4% | 403,000 |
| 2022/07/01 | 1,142 | 1,162 | 1,112 | 1,120 | -10 | -0.9% | 664,200 |
| 2022/06/30 | 1,140 | 1,152 | 1,122 | 1,130 | -7 | -0.6% | 520,600 |
| 2022/06/29 | 1,140 | 1,150 | 1,125 | 1,137 | -24 | -2.1% | 588,700 |
| 2022/06/28 | 1,121 | 1,166 | 1,121 | 1,161 | +35 | +3.1% | 1,047,500 |
| 2022/06/27 | 1,116 | 1,133 | 1,104 | 1,126 | +16 | +1.4% | 547,900 |
| 2022/06/24 | 1,100 | 1,116 | 1,087 | 1,110 | +35 | +3.3% | 898,100 |
| 2022/06/23 | 1,031 | 1,090 | 1,028 | 1,075 | +44 | +4.3% | 869,800 |
| 2022/06/22 | 1,040 | 1,044 | 1,018 | 1,031 | -2 | -0.2% | 389,100 |
| 2022/06/21 | 1,012 | 1,039 | 1,012 | 1,033 | +30 | +3% | 458,400 |
| 2022/06/20 | 1,026 | 1,035 | 991 | 1,003 | -16 | -1.6% | 729,300 |
| 2022/06/17 | 1,033 | 1,054 | 1,016 | 1,019 | -44 | -4.1% | 893,000 |
| 2022/06/16 | 1,101 | 1,106 | 1,062 | 1,063 | -16 | -1.5% | 589,300 |
| 2022/06/15 | 1,102 | 1,116 | 1,079 | 1,079 | -26 | -2.4% | 694,500 |
| 2022/06/14 | 1,162 | 1,162 | 1,090 | 1,105 | -77 | -6.5% | 1,280,500 |
| 2022/06/13 | 1,181 | 1,199 | 1,165 | 1,182 | -29 | -2.4% | 831,600 |
| 2022/06/10 | 1,198 | 1,217 | 1,182 | 1,211 | -4 | -0.3% | 657,200 |
| 2022/06/09 | 1,196 | 1,222 | 1,190 | 1,215 | +32 | +2.7% | 639,400 |
| 2022/06/08 | 1,154 | 1,189 | 1,153 | 1,183 | +41 | +3.6% | 822,500 |
| 2022/06/07 | 1,144 | 1,151 | 1,133 | 1,142 | -12 | -1% | 449,100 |
| 2022/06/06 | 1,136 | 1,159 | 1,132 | 1,154 | +3 | +0.3% | 484,600 |
| 2022/06/03 | 1,152 | 1,162 | 1,146 | 1,151 | +19 | +1.7% | 366,200 |
| 2022/06/02 | 1,150 | 1,150 | 1,125 | 1,132 | -36 | -3.1% | 602,000 |
| 2022/06/01 | 1,155 | 1,183 | 1,155 | 1,168 | +15 | +1.3% | 428,700 |
| 2022/05/31 | 1,166 | 1,175 | 1,152 | 1,153 | -29 | -2.5% | 530,900 |
| 2022/05/30 | 1,162 | 1,183 | 1,154 | 1,182 | +39 | +3.4% | 611,800 |
| 2022/05/27 | 1,171 | 1,174 | 1,140 | 1,143 | -8 | -0.7% | 451,200 |
| 2022/05/26 | 1,147 | 1,173 | 1,146 | 1,151 | +2 | +0.2% | 529,800 |
| 2022/05/25 | 1,158 | 1,173 | 1,147 | 1,149 | -30 | -2.5% | 532,300 |
| 2022/05/24 | 1,208 | 1,220 | 1,177 | 1,179 | -59 | -4.8% | 865,600 |
| 2022/05/23 | 1,187 | 1,238 | 1,185 | 1,238 | +60 | +5.1% | 663,300 |
| 2022/05/20 | 1,149 | 1,184 | 1,146 | 1,178 | +50 | +4.4% | 497,900 |
| 2022/05/19 | 1,121 | 1,139 | 1,117 | 1,128 | -34 | -2.9% | 750,900 |
| 2022/05/18 | 1,155 | 1,176 | 1,145 | 1,162 | +11 | +1% | 436,000 |
| 2022/05/17 | 1,160 | 1,160 | 1,133 | 1,151 | ±0 | ±0% | 442,400 |
| 2022/05/16 | 1,185 | 1,216 | 1,138 | 1,151 | +11 | +1% | 1,164,000 |
| 2022/05/13 | 1,132 | 1,151 | 1,121 | 1,140 | +38 | +3.4% | 927,800 |
| 2022/05/12 | 1,156 | 1,157 | 1,102 | 1,102 | -82 | -6.9% | 1,241,700 |
| 2022/05/11 | 1,162 | 1,201 | 1,153 | 1,184 | +22 | +1.9% | 768,700 |
| 2022/05/10 | 1,157 | 1,177 | 1,146 | 1,162 | -7 | -0.6% | 748,300 |
| 2022/05/09 | 1,195 | 1,204 | 1,165 | 1,169 | -41 | -3.4% | 944,200 |
| 2022/05/06 | 1,245 | 1,245 | 1,210 | 1,210 | -44 | -3.5% | 641,400 |
| 2022/05/02 | 1,261 | 1,267 | 1,246 | 1,254 | -23 | -1.8% | 470,800 |
| 2022/04/28 | 1,264 | 1,279 | 1,264 | 1,277 | +16 | +1.3% | 407,900 |
| 2022/04/27 | 1,245 | 1,263 | 1,232 | 1,261 | -6 | -0.5% | 522,300 |
551～
600
件表示中 / 4944件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 246,000円 | +7.6% | +57.5% | 2.15% | 19.02倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
